A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA

NCT03764618 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Warm Antibody Autoimmune Hemolytic Anemia

Interventions

DRUG: Fostamatinib disodium
DRUG: Placebo

Sponsor

Rigel Pharmaceuticals